22.04.2013
- AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system...
19.04.2013
- Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at...
18.04.2013
- The specialty chemicals company Lanxess has opened a new Asia-Pacific Application Development Center for its high-tech plastics in the Hong Kong Science & Technology Park. It is...
15.04.2013
- BASF is taking firm steps to stop the distribution of counterfeit versions of its Irgacure 819 photoinitiator product. After repeatedly issuing notifications, BASF has contacted...
13.04.2013
- Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China - typically the first step in making a flu vaccine - government-backed...
11.04.2013
- Wacker Chemie is strengthening its presence in South America, and today inaugurates its expanded technical center, including training center, near São Paulo, Brazil. The new...
10.04.2013
- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said...
08.04.2013
- U.S. drugmaker Bristol-Myers Squibb said on Sunday it has named Francis Cuss to become its next chief scientific officer after Elliott Sigal retires as head of research and...
